Exclusivity Information
Sedivet holds 1 exclusivity out of which 1 has expired. Details of Sedivet's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Jun 03, 2009 |
About Sedivet
Sedivet is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Sedivet uses
Romifidine Hydrochloride as the active
ingredient.
Active Ingredient:
Sedivet uses
Romifidine Hydrochloride as the active ingredient.
Check out other Drugs and Companies using
Romifidine Hydrochloride ingredient.